← Search

Text · study · 2026

Antibodies derived from patient tumors augment response to immune checkpoint blockade in cancer

Listed in NCBI GEO

B-cells are associated with favorable response to immunotherapy, though the underlying mechanisms remain unclear.

Description

Here, we profiled tumor-infiltrating B-cells (TIL-Bs) and tertiary lymphoid structures (TLS) from α-PD-1 + α-CTLA-4 treated responders (R) and non-responders (NR) to identify immune signatures. TLS from responders exhibited upregulated inflammatory genes, and increased levels of cytotoxic immune cells.

Links

Where it is published

Documentation and papers

Topics

Stated by source
Homo sapiens · Other
From keywords
Life Sciences
Inferred from text
Cancer 75%
Provenance · 1 source records, 8 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE33132214 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:othersource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title